CMC Project Lead

Sweden, Gothenburg
01 Apr 2021
15 Apr 2021
Regulatory Affairs, CMC
Full Time
Contract Type
Experience Level
Experienced (non-manager)

At AstraZeneca we're dedicated to being a Great Place to Work. Where you are empowered to push the boundaries of science and unleash your entrepreneurial spirit. There's no better place to make a difference to medicine, patients and society. An inclusive culture that champions diversity and collaboration. Always committed to lifelong learning, growth and development. If you have the passion and the drive to accelerate growth and make people's lives better - then this is the place for you.

Pharmaceutical Sciences at AstraZeneca deliver the therapies of the future through scientific leadership in drug delivery, design of synthetic routes, and manufacturing of Active Pharmaceutical Ingredients (API) and drug products. Our portfolio of projects spans small molecules, peptides, oligonucleotides to RNA-based therapeutics across AstraZeneca's therapy areas. Sciences with a mission to provide novel products to AstraZeneca's clinical pipeline.

We are now looking for a talented, motivated and experienced CMC Project Lead to join our CVRM (cardiovascular, renal and metabolism) CMC project leadership team in Gothenburg, with Boston as an alternative location.

The CMC Project Lead is a key leadership position within the Pharmaceutical Sciences function, delivering a rich portfolio comprising an exciting mixture of small molecules and new modalities.

The selected candidate will be accountable for leadership, strategy & planning as well as delivery and budget management for the CMC contribution to a small portfolio of projects prior to Ph3. Depending on complexity and the stage of development, you will lead 2-6 projects.

You are expected to take a holistic view of CMC activities as well a working knowledge of other scientific disciplines in AZ BioPharma R&D and deliver innovative and differentiated strategies that balance scientific risks against return on investment.

This is an important role, giving you a chance to influence R&D science, portfolio strategies and product development, and contribute to the success of AstraZeneca's portfolio.You will report to the Pharmaceutical Sciences Head of CVRM CMC project leadership.

Essential Requirements - Experience, skills, capabilities

  • Advanced degree in science in relevant scientific discipline

  • Significant experience of working within a CMC organisation and insight into how CMC contributes to the wider medicine development process

  • Global drug development experience

  • Broad experience working with both small and large synthetic molecules

  • Experience of project management/leadership in a large and complex business environment, preferably within an international environment and experience of working with external partners

  • Proven track record in all aspects of creating and leading large scientific, multi-disciplinary high performing teams, such as: excellent communication skills, strong business acumen and creative problem-solving capabilities, ability to analyze and interpret complex situations in order to provide clear strategic directions for others

Why AstraZeneca?
We are a global, science-led BioPharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Our team is inclusive and respectful - we share to expand our minds and explore new areas. Curious problem-solvers, it's in our DNA to keep digging, ask questions and achieve together!

What's next!
Are you ready to bring new ideas and fresh thinking to the table and be part of our excellent team - apply today and we'll make it happen together! We welcome your application (including CV and cover letter) no later than April 15, 2021.
If you have any questions about this role, please contact Britta Polentarutti, Head of CVRM CMC Projects, at

Where can I find out more?
Follow AstraZeneca on LinkedIn
Follow AstraZeneca on Facebook
Follow AstraZeneca on Instagram

Competitive salary and benefits package on offer.
Opening date: 1st April
Closing date: 15th April